Greenleaf Trust’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.52M | Sell |
24,165
-1,273
| -5% | -$102K | 0.01% | 250 |
|
|
2025
Q4 | $2.43M | Sell |
25,438
-1,157
| -4% | -$113K | 0.02% | 171 |
|
|
2025
Q3 | $2.6M | Sell |
26,595
-175
| -0.7% | -$18.1K | 0.02% | 160 |
|
|
2025
Q2 | $2.88M | Sell |
26,770
-1,488
| -5% | -$151K | 0.03% | 148 |
|
|
2025
Q1 | $2.85M | Buy |
28,258
+1,665
| +6% | +$168K | 0.03% | 150 |
|
|
2024
Q4 | $2.38M | Buy |
26,593
+1,291
| +5% | +$114K | 0.02% | 173 |
|
|
2024
Q3 | $2.12M | Sell |
25,302
-181
| -0.7% | -$14.3K | 0.02% | 189 |
|
|
2024
Q2 | $1.96M | Buy |
25,483
+944
| +4% | +$69.1K | 0.02% | 183 |
|
|
2024
Q1 | $1.68M | Sell |
24,539
-195
| -0.8% | -$12.5K | 0.02% | 210 |
|
|
2023
Q4 | $1.43M | Buy |
24,734
+2,197
| +10% | +$117K | 0.02% | 226 |
|
|
2023
Q3 | $1.19M | Buy |
22,537
+495
| +2% | +$26K | 0.01% | 234 |
|
|
2023
Q2 | $1.19M | Sell |
22,042
-1,180
| -5% | -$61.6K | 0.01% | 240 |
|
|
2023
Q1 | $1.16M | Buy |
23,222
+1,890
| +9% | +$89.1K | 0.01% | 251 |
|
|
2022
Q4 | $987K | Buy |
21,332
+2,261
| +12% | +$97.9K | 0.01% | 272 |
|
|
2022
Q3 | $739K | Buy |
19,071
+2,316
| +14% | +$92.9K | 0.01% | 292 |
|
|
2022
Q2 | $624K | Sell |
16,755
-1,294
| -7% | -$52.7K | 0.01% | 338 |
|
|
2022
Q1 | $799K | Buy |
18,049
+1,770
| +11% | +$76.7K | 0.01% | 292 |
|
|
2021
Q4 | $692K | Buy |
16,279
+1,584
| +11% | +$66.6K | 0.01% | 332 |
|
|
2021
Q3 | $638K | Buy |
14,695
+1,214
| +9% | +$53.7K | 0.01% | 334 |
|
|
2021
Q2 | $576K | Buy |
13,481
+649
| +5% | +$27.3K | 0.01% | 361 |
|
|
2021
Q1 | $496K | Buy |
12,832
+3,929
| +44% | +$149K | 0.01% | 377 |
|
|
2020
Q4 | $320K | Sell |
8,903
-2,356
| -21% | -$84.9K | ﹤0.01% | 438 |
|
|
2020
Q3 | $430K | Buy |
11,259
+2,205
| +24% | +$85K | 0.01% | 322 |
|
|
2020
Q2 | $318K | Buy |
9,054
+846
| +10% | +$30.5K | 0.01% | 385 |
|
|
2020
Q1 | $268K | Sell |
8,208
-2,547
| -24% | -$99.5K | 0.01% | 360 |
|
|
2019
Q4 | $486K | Sell |
10,755
-125
| -1% | -$5.23K | 0.01% | 294 |
|
|
2019
Q3 | $443K | Buy |
10,880
+560
| +5% | +$23.7K | 0.01% | 308 |
|
|
2019
Q2 | $444K | Buy |
10,320
+502
| +5% | +$19.3K | 0.01% | 305 |
|
|
2019
Q1 | $377K | Buy |
9,818
+733
| +8% | +$28K | 0.01% | 329 |
|
|
2018
Q4 | $321K | Buy |
9,085
+1,057
| +13% | +$38.3K | 0.01% | 350 |
|
|
2018
Q3 | $309K | Buy |
+8,028
| New | +$280K | 0.01% | 388 |
|
|
2018
Q1 | – | Sell |
-392
| Closed | -$10K | – | 553 |
|
|
2017
Q4 | $10K | Sell |
392
-53
| -12% | -$1.46K | ﹤0.01% | 655 |
|
|
2017
Q3 | $13K | Buy |
+445
| New | +$12.3K | ﹤0.01% | 637 |
|
Other funds holding BSX
VCM
VPM
Greenleaf Trust's BSX Position: Q1 2026 in Review
Greenleaf Trust reduced its Boston Scientific (BSX) stake by 5% in Q1 2026, selling an estimated $102K and leaving 24,165 shares worth $1.52M. The position accounts for 0.01% of the portfolio, ranked #250.
Greenleaf Trust first reported a position in BSX in Q3 2017 and has held it in 33 quarters since. The position peaked at $2.88M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Greenleaf Trust held 24,165 shares of Boston Scientific worth $1.52M as of Q1 2026.
- Greenleaf Trust sold 1,273 Boston Scientific shares in Q1 2026, an estimated $102K.
- Boston Scientific made up 0.01% of Greenleaf Trust's portfolio in Q1 2026, its #250 holding.
- Greenleaf Trust first reported a position in Boston Scientific in Q3 2017 and has held it in 33 quarters since.
- Greenleaf Trust's Boston Scientific position peaked at $2.88M in Q2 2025.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Greenleaf Trust's 13F filing for Q1 2026, filed 27 Apr 2026.